THIS month's edition of the Society of Hospital Pharmacists of Australia's Journal of Pharmacy Practice and Research (JPPR) focuses on medicines deprescribing, saying "mitigation of sub-therapeutic or potentially harmful polypharmacy as integral to all pharmacy practice".
An editorial by Editor-in-Chief of the SHPA flagship journal, Dr Chris Alderman, questions why the deprescribing movement is still struggling to find widespread traction, while other articles feature 10 recommendations for system-level improvements in the quality use of medications for older people in Australia.
The Oct issue of JPPR is out now and is available free to SHPA members - see shpa.org.au/jppr.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Oct 18
